Results 81 to 90 of about 4,730,209 (296)

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

open access: yesMolecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande   +11 more
wiley   +1 more source

Larson's third law and the universality of molecular cloud structure

open access: yes, 2010
Larson (1981) first noted a scaling relation between masses and sizes in molecular clouds that implies that these objects have approximately constant column densities.
Ballesteros-Paredes   +24 more
core   +1 more source

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

open access: yesMolecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece   +18 more
wiley   +1 more source

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

open access: yesMolecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir   +12 more
wiley   +1 more source

The HI column density distribution function in faint dwarf galaxies

open access: yes, 2012
We present the HI column density distribution function,\fnh, as measured from dwarf galaxies observed as part of the Faint Irregular Galaxy GMRT (FIGGS) survey.
Begum, Ayesha   +2 more
core   +1 more source

Analysis of the behavior of reinforced concrete columns strengthened with sleeve wedge bolts and a self compacting concrete layer

open access: yesRevista IBRACON de Estruturas e Materiais
Strengthening of reinforced concrete columns by jacketing is one of the most common structural rehabilitation techniques in Brazil. For adequate performance, it is necessary, among others, to avoid detachment of the new concrete layer (strengthening ...
M. G. Marques   +3 more
doaj   +1 more source

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

open access: yesMolecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia   +9 more
wiley   +1 more source

Method of evaporation [PDF]

open access: yes, 1987
Liquids, such as juices, milk, molten metal and the like are concentrated by forming uniformly-sized, small droplets in a precision droplet forming assembly and deploying the droplets in free fall downwardly as a central column within an evacuated column
Dufresne, Eugene R.
core   +1 more source

Methods of analysis of a reinforced concrete section under bending with axial force in the post-yield range

open access: yesBudownictwo i Architektura, 2014
Predicting the behaviour of plastic hinges subjected to large inelastic deformations caused by extreme loads such as earthquakes plays an important role in assessing maximum stable deformation capacities of framed concrete structures. This paper presents
Jacek Korentz
doaj   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

open access: yesMolecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy